Royalty Pharma to Acquire Its External Manager in a Transaction Valued at $1.1 Billion
January 14, 2025
January 14, 2025
BOSTON, Massachusetts, Jan. 14 -- Goodwin, a law firm, issued the following news release:
Goodwin's Public M&A team advised Morgan Stanley & Co. LLC as financial advisor to Royalty Pharma plc ("Royalty Pharma", NASDAQ: RPPX) as it entered into an agreement to acquire its external manager, RP Management, LLC ("RP Management"), in a transaction valued at approximately $1.1 billion. Under the terms of the agreement, Royalty Pharma will pay $200 million . . .
Goodwin's Public M&A team advised Morgan Stanley & Co. LLC as financial advisor to Royalty Pharma plc ("Royalty Pharma", NASDAQ: RPPX) as it entered into an agreement to acquire its external manager, RP Management, LLC ("RP Management"), in a transaction valued at approximately $1.1 billion. Under the terms of the agreement, Royalty Pharma will pay $200 million . . .